Evotec and Takeda in Drug Discovery Pact
German drug discovery and development company Evotec has entered into a strategic, multi-year collaboration with Japan’s Takeda Pharmaceutical that could be worth in excess of $850 million. read more
View ArticleTakeda Sells OTC Drugs to Acino
In another move to reduce debt after buying Shire early this year, Japanese drugmaker Takeda has agreed to sell roughly 30 prescription pharmaceuticals and over-the-counter (OTC) products to Swiss...
View ArticleTakeda Buys Celiac License from Cour
Japan’s Takeda Pharmaceutical has bought an exclusive global license to an investigational therapy for celiac disease from US biotech Cour Pharmaeuticals.Takeda will develop and commercialize the...
View ArticleStada Takes Part of Takeda’s CIS Portfolio
In the largest acquisition in the company’s history, German generics producer Stada is paying $660 million to take some of the over-the-counter and prescription drugs portfolio of Japanese...
View ArticleShire Passes on Irish Tax Bill to Takeda
Japanese drugmaker Takeda is facing a large tax bill from Ireland as an uncalculated repercussion of its acquisition of US-managed, Ireland-domiciled Shire at the end of 2018.Tax authorities in Dublin...
View ArticleAstraZeneca Aims to be Carbon Neutral by 2025
Anglo-Swedish drugmaker AstraZeneca plans to invest up to $1 billion in a scheme it calls Ambition Zero Carbon, which as the name suggests is aimed at achieving zero carbon emissions from its global...
View ArticleTakeda and Charles River in Drug Discovery Pact
Japanese drugmaker Takeda has entered into a multi-year drug discovery collaboration with contract research organization (CRO) Charles River.read more
View ArticleTakeda Takes PvP Biologics
Japanese drugmaker Takeda Pharmaceutical has acquired PvP Biologics, following the conclusion of a Phase 1 proof-of-mechanism study of TAK-062 (Kuma062), an investigational treatment for uncontrolled...
View ArticleTakeda and Evox Link on Rare Diseases
Japan’s Takeda Pharmaceutical is partnering with UK biotech Evox Therapeutics to develop treatments for rare diseases. Financial terms of the agreement have not been disclosed.read more
View ArticleTakeda Sells OTC Drugs to Denmark’s Orifarm
Takeda Pharmaceutical has agreed to sell a selection of the over-the-counter (OTC) and prescription drugs it markets in Europe to fast-growing Danish pharma Orifarm for a total of about $670...
View Article
